Dragon and Tiger List | Lionco (603669) hits the daily limit, reason for listing: the closing price increase deviation of the top five securities with a price fluctuation limit reaches 7%
I'm LongbridgeAI, I can summarize articles.On June 8th, Lionco (603669) appeared on the leaderboard due to a closing price deviation of 7%. The stock hit the daily limit, closing at 4.48 yuan, with a turnover rate of 5.85%. The leaderboard showed a net purchase of 5.9902 million yuan, mainly from the headquarters of Huatai Securities and related positions of Guotai Haitong Securities. Financial data indicates that the company's revenue in 2025 is expected to be 322 million yuan, a year-on-year decline of 15.09%, with a net loss attributable to the parent company of 193 million yuan
According to Tongbi Finance, on June 8, Lionco (603669) appeared on the Dragon and Tiger List. The reason for being listed: this stock is among the top five securities with a closing price deviation of 7% on a day with price fluctuation limits. The buying amount on the Dragon and Tiger List was 44.3065 million yuan, the selling amount was 38.3164 million yuan, and the net buying amount was 5.9902 million yuan.
The top 5 buying amounts totaled 44.3065 million yuan. Among them, the first buying position was Huatai Securities Co., Ltd. headquarters, buying 12.5633 million yuan; the second position was Guotai Haitong Securities Co., Ltd. headquarters, buying 12.3073 million yuan; the third position was Guotai Haitong Securities Co., Ltd. Shanghai Putuo District Daduhe Road Securities Business Department, buying 8.2325 million yuan; the fourth position was China International Capital Corporation Shanghai Branch, buying 5.6434 million yuan; the fifth position was Northeast Securities Co., Ltd. Changchun Satellite Road Securities Business Department, buying 5.5601 million yuan.
The top 5 selling amounts totaled 38.3164 million yuan. Among them, the first selling position was Hualin Securities Co., Ltd. Beijing Shijingshan Road Securities Business Department, selling 8.7987 million yuan; the second position was Goldman Sachs (China) Securities Co., Ltd. Shanghai Pudong New District Century Avenue Securities Business Department, selling 8.565 million yuan; the third position was Guotai Haitong Securities Co., Ltd. headquarters, selling 7.6943 million yuan; the fourth position was Guoyuan Securities Co., Ltd. Shenzhen Yitian Road Securities Business Department, selling 6.6629 million yuan; the fifth position was Huachuang Securities Co., Ltd. Anshun Hongshan Lake Road Securities Business Department, selling 6.5955 million yuan.
As of the close on June 8, Lionco (603669) hit the daily limit, with a closing price of 4.48 yuan, a market capitalization of 3.191 billion yuan, and a turnover rate of 5.85%.
Tongbi Finance Tip:
Lionco (603669.SH) reported an operating income of 322 million yuan in 2025, with a revenue growth rate of -15.09%, and a net profit attributable to the parent company of -193 million yuan, with a net profit growth rate of -47.78%, and a return on equity of -28.91%.
In the first quarter of 2026, the company reported an operating income of 87 million yuan, with a revenue growth rate of 72.65%, and a net profit attributable to the parent company of 3 million yuan, with a net profit growth rate of 115.87%.
Currently, the company belongs to the healthcare industry, with the main product type being active pharmaceutical ingredients. The 2025 report shows the main composition of pharmaceutical distribution: 46.46%; cardiovascular and cerebrovascular: 28.34%; anti-infection: 10.22%; other products: 4.15%; parenteral nutrition: 4.05%; other contract-generated income: 3.31%; digestive system: 1.64%; hospital sales and distribution income: 0.92%; leasing: 0.91%.